ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,937Medicare Part D Prescriptions Filled, Including Refills

Rank: 611 out of 2343

$393K Total Retail Price of All Prescriptions

Rank: 926 out of 2343

357 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 357 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 357 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,063 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 629 561 1 1
LEVOTHYROXINE SODIUM 268 265 2 2
AMLODIPINE BESYLATE 262 241 3 5
ATENOLOL 246 228 4 12
LISINOPRIL 216 186 5 3
FAMOTIDINE 202 189 6 60
FUROSEMIDE 194 174 7 6
METOPROLOL TARTRATE 194 174 7 7
POTASSIUM CHLORIDE 184 174 9 18
ENALAPRIL MALEATE 162 152 10 58
LOSARTAN POTASSIUM 151 148 11 19
OMEPRAZOLE 139 125 12 4
FLUTICASONE PROPIONATE 136 118 13 46
HYDROCODONE-ACETAMINOPHEN 134 105 S3 14 13
METFORMIN HCL 132 100 15 9
ATORVASTATIN CALCIUM 127 114 16 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 97 17 42
METOPROLOL SUCCINATE 114 109 18 14
WARFARIN SODIUM 111 102 19 8
TAMSULOSIN HCL 107 82 20 29
ZOLPIDEM TARTRATE 102 85 21 24
VERAPAMIL ER 96 74 22 95
HYDROCHLOROTHIAZIDE 94 69 23 11
AZITHROMYCIN 92 86 24 39
PRAVASTATIN SODIUM 90 76 25 15
MELOXICAM 90 87 25 68
CIPROFLOXACIN HCL 87 80 27 72
GLIMEPIRIDE 84 75 28 45
PREDNISONE 82 77 29 37
FINASTERIDE 82 80 29 80
OXYCODONE-ACETAMINOPHEN 80 59 S2 31 49
PANTOPRAZOLE SODIUM 75 75 32 22
DONEPEZIL HCL 74 74 33 21
RAMIPRIL 72 72 34 90
DIGOXIN 72 72 34 35
ESCITALOPRAM OXALATE 68 40 36 55
METHYLPREDNISOLONE 68 62 36 122
CLOPIDOGREL 67 67 38 26
INDAPAMIDE 66 66 39 170
TRIAMTERENE-HCTZ 66 65 39 57
CARBIDOPA-LEVODOPA 66 66 39 85
DOXAZOSIN MESYLATE 65 63 42 98
FENTANYL 62 62 S2 43 69
SYNTHROID 62 62 43 40
CELEBREX 61 61 45 71
PLAVIX 61 61 45 38
FLUOXETINE HCL 57 46 47 82
VENLAFAXINE HCL ER 56 47 48 87
TRIAMCINOLONE ACETONIDE 56 47 48 137
SPIRONOLACTONE 56 56 48 65
AMITRIPTYLINE HCL 51 45 R 51 117
ADVAIR DISKUS 50 45 52 34
NEXIUM 50 50 52 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.